Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients

Journal of Crohn's and Colitis

Volumn 7, Issue 4, 2013, Pages 308-313

  Naganuma, Makoto ^a   Fujii, Toshimitsu ^a   Kunisaki, Reiko ^b   Yoshimura, Naoki ^c   Takazoe, Masakazu ^c   Takeuchi, Yoshiaki ^d   Saito, Eiko ^a   Nagahori, Masakazu ^a   Asakura, Keiko ^e   Takebayashi, Toru ^e   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Social Insurance Central General Hospital   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Immunomodulators; Inflammatory bowel disease; Influenza A (H1N1); Steroids

Indexed keywords

ADALIMUMAB; ANTIVIRUS AGENT; CERTOLIZUMAB PEGOL; CORTICOSTEROID; INFLIXIMAB; INFLUENZA VACCINE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; STEROID; TACROLIMUS;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; CROHN DISEASE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84875265214     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.06.019     Document Type: Article

References (21)

1. Ginsberg M., Hopkins J., Maroufi A., Dunne G., Sunega D.R., Giessick J., et al. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Recomm Rep 2009, 58:400-402.
2. Rahier J.F., Yazdanpanah Y., Viget N., Travis S., Colombel J.F. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010, 31:5-10.
3. Fraser C., Donnelly C.A., Cauchemez S., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009, 324:1557-1561.
4. Cullen G., Bader C., Korzenik J.R., Sands B.E. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut 2012, 61:385-391.
5. Epple H.J. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig Dis 2009, 27:555-559.
6. Aberra F.N., Lichtenstein G.R. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:685-695.
7. Toruner M., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Orenstein R., Sandborn W.J., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008, 134:929-936.
8. Viget N., Vernier-Massouille G., Salmon-Ceron D., Yazdanpanah Y., Colombel J.F. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008, 5:549-558.
9. Afif W., Loftus E.V. Safety profile of IBD therapeutics: infectious risks. Med Clin North Am 2010, 94:115-133.
10. Tone M., Renna S. IBD: incidence of HSV and HPV with azathioprine. Nat Rev Gastroenterol Hepatol 2009, 6:444-445.
11. Lawrance I.C., Radford-Smith G.L., Bampton P.A., Andrews J.M., Tan P.K., Croft A., et al. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience. J Gastroenterol Hepatol 2010, 25:1732-1738.
12. Rahier J.F., Ben-Horin S., Chowers Y., Colon C., De Munter P., D'Haens G., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009, 3:47-91.
13. Naganuma M., Kunisaki R., Yoshimura N., Nagahori M., Yamamoto H., Kimura Y., et al. Conception and pregnancy outcome in women with inflammatory bowel disease: a multicentre study from Japan. J Crohns Colitis 2011, 5:317-323.
14. Yang Z.F., Zhan Y.Q., Chen R.C., Zhou R., Wang Y.T., Luo Y., et al. A prospective comparison of the epidemiological and clinical characteristics of pandemic (H1N1) 2009 influenza A influenza virus and seasonal influenza A viruses in Guangzhou, South China in 2009. Jpn J Infect Dis 2012, 65:208-214.
15. Broor S., Krishnan A., Roy D.S., Dhakad S., Kaushik S., Mir M.A., et al. Dynamic patterns of circulating seasonal and pandemic A (H1N1) pdm09 influenza viruses from 2007-2010 in and around Delhi, India. PLoS One 2012, 7:e29129.
16. Rajatonirina S., Heraud J.M., Orelle A., Randrianasolo L., Razanajatovo N., Rajaona Y.R., et al. The spread of influenza A (H1N1) pdm09 virus in Madagascar described by a sentinel surveillance network. PLoS One 2012, 7:e37067.
17. WHO Wkly Epidemiol Rec 2009, 84:249-260.
18. Takayama K., Kuramochi J., Oinuma T., Kaneko H., Kurasawa S., Yasui M., et al. Clinical features of 2009 swine-origin influenza A (H1N1) outbreak in Japan. Infect Chemother 2011, 17:401-406.
19. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Eng J Med 2009, 361:1945-1952.
20. Belongia E.A., Irving S.A., Waring S.C., Coleman L.A., Meece J.K., Vandermause M., et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010, 304:1091-1098.
21. Rahier J.F., Papay P., Salleron J., Sebastian S., Ellul P., Teich N., et al. Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. Aliment Pharmacol Ther 2011, 33:499-500.